MYD88 and metabolic dysfunction-associated steatohepatitis: Another previous work confirmed the protective effect of myricetin against liver fibrosis in a diet-induced non-alcoholic steatohepatitis rat model through inhibiting the TREM-1-TLR2/4-MyD88 signaling molecules in macrophages69.